SunWay Biotech had earned recognition from President Tsai of Taiwan
President Tsai Ing-wen met the 2022 Outstanding Biotechnology Industry Award winners on 23rd February. She emphasized that the government will continue to invest resources and adjust and amend relevant laws and regulations to improve the competitiveness of the biotechnology and medical industry continuously. Thus, technology and medical enterprises will develop more vigorously and create more welfare for the public.
SunWay Biotech is committed to applying diverse and effective microorganisms and developing efficient and unique fermentation processes to provide high-quality products that ensure carefree health across the globe. In addition to winning the Taiwan BIO Award-Advanced National Innovation Award” for two consecutive years in 2020 and 2021, SunWay was honored to be awarded the Gold Award of 2022 Taiwan BIO Award! SunWay was invited to meet with President Tsai and discuss with the President and other participants how to continuously improve the competitiveness of the biotechnology and medical industry and become Taiwan’s next trillion-dollar industry!
President John Pan of SunWay Biotech also expressed his gratitude to every colleague, customer, shareholder, and the most important technological inventor, Professor Tzu-Ming Pan, for allowing SunWay to create another sacred mountain for Taiwan!
Source: Office of the President
Related posts
Happy Dragon Boat Festival From your friends at SunWay Biotech!
Happy Dragon Boat Festival From your friends at SunWay Biotech! All of us at SunWay Biotech want to thank you for your business and support. Our office will be closed for Dragon Boat Festival on 3 June and will get back to regular operation starting from 5 June. For emergency during this period, please contact us by email. We will get back to you as soon as possible.
Recommendations regarding red yeast rice supplementation
An international panel of lipid experts issued recommendations regarding red yeast rice supplementation that People who are ❗️ unwilling to take a statin or other lipid-lowering drug or ❗️ with confirmed statin intolerance may consider red yeast rice supplementation People who are ❗️ hypersensitivity to monacolin K/lovastatin or any of the excipients ❗️ acute liver disease or severe renal impairment (eGFR <30 mL/min), or ❗️ with a muscle disease 👉should not consider taking traditional red yeast rice supplement. (which means red yeast rice supplement containing monacolin K) Using only red yeast rice manufactured according to ✅ good manufacturing practices and ✅ containing no more than about 2 ppm of citrinin. (EU’s maximum levels of citrinin: 100 ppb) SunWay Biotech applies the strictest limit, ANKASCIN 568-R, the only red yeast rice that doesn’t contain any Monacolin K/lovastain in the world. All of its benefits and safety are verified by clinical studies and liver/kidney safety assessments. Thus, consumers do not need to be concerned about drug interactions or overdose. Furthermore, ANKASCIN 568-R goes through a patented extraction process that can comply with the regulations of citrinin for each country. We are guaranteed that this ingredient will start a new page for your consumers.💪💪 Source: https://lnkd.in/gBDE-q-c https://lnkd.in/g8yTnSTc
Interview from PharmaBoardRoom: George J. Lee, Ph.D. – Chairman; Tzu-Ming Pan, Ph.D – Vice Chairman and Chief Technology and Science Officer, SunWay Biotech, Taiwan
George Lee and Tzu-Ming Pan introduce SunWay Biotech’s groundbreaking red yeast rice extract, ANKASCIN® 568-R, which has been recognized as a New Dietary Ingredient by the US FDA. SunWay Biotech is now bringing this unique product onto the global stage and are considering developing a pharmaceutical product based on the same compounds.